KR920703038A - 크립토스포리디아중(cryptosporidiosis)의 치료약제 - Google Patents
크립토스포리디아중(cryptosporidiosis)의 치료약제Info
- Publication number
- KR920703038A KR920703038A KR1019920700869A KR920700869A KR920703038A KR 920703038 A KR920703038 A KR 920703038A KR 1019920700869 A KR1019920700869 A KR 1019920700869A KR 920700869 A KR920700869 A KR 920700869A KR 920703038 A KR920703038 A KR 920703038A
- Authority
- KR
- South Korea
- Prior art keywords
- chlorophenyl
- cyclohexyl
- hydroxy
- compound
- animal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8923254.0 | 1989-10-16 | ||
GB898923254A GB8923254D0 (en) | 1989-10-16 | 1989-10-16 | Medicaments |
PCT/GB1989/001287 WO1991005550A1 (en) | 1989-10-16 | 1989-10-26 | Medicament for the treatment of cryptosporidiosis |
Publications (1)
Publication Number | Publication Date |
---|---|
KR920703038A true KR920703038A (ko) | 1992-12-17 |
Family
ID=10664644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920700869A KR920703038A (ko) | 1989-10-16 | 1989-10-26 | 크립토스포리디아중(cryptosporidiosis)의 치료약제 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0496729B1 (de) |
JP (1) | JPH05502435A (de) |
KR (1) | KR920703038A (de) |
AT (1) | ATE107504T1 (de) |
AU (1) | AU637772B2 (de) |
CA (1) | CA2001566A1 (de) |
DE (1) | DE68916443T2 (de) |
DK (1) | DK50092A (de) |
GB (1) | GB8923254D0 (de) |
HU (1) | HU208625B (de) |
IE (1) | IE893450A1 (de) |
MC (1) | MC2203A1 (de) |
WO (1) | WO1991005550A1 (de) |
ZA (1) | ZA898143B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9126874D0 (en) * | 1991-12-18 | 1992-02-19 | Wellcome Found | Medicaments |
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
GB9226905D0 (en) * | 1992-12-24 | 1993-02-17 | Wellcome Found | Pharmaceutical preparation |
GB9613309D0 (en) * | 1996-06-25 | 1996-08-28 | Univ Sheffield | Quinone bacterial inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8310140D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Antiprotozoal agents |
GB8310141D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Naphthoquinone derivatives |
-
1989
- 1989-10-16 GB GB898923254A patent/GB8923254D0/en active Pending
- 1989-10-26 EP EP89912649A patent/EP0496729B1/de not_active Expired - Lifetime
- 1989-10-26 CA CA002001566A patent/CA2001566A1/en not_active Abandoned
- 1989-10-26 KR KR1019920700869A patent/KR920703038A/ko not_active Application Discontinuation
- 1989-10-26 IE IE345089A patent/IE893450A1/en unknown
- 1989-10-26 JP JP1511681A patent/JPH05502435A/ja active Pending
- 1989-10-26 WO PCT/GB1989/001287 patent/WO1991005550A1/en active IP Right Grant
- 1989-10-26 ZA ZA898143A patent/ZA898143B/xx unknown
- 1989-10-26 AU AU45192/89A patent/AU637772B2/en not_active Ceased
- 1989-10-26 MC MC891287D patent/MC2203A1/xx unknown
- 1989-10-26 HU HU9201295A patent/HU208625B/hu not_active IP Right Cessation
- 1989-10-26 AT AT89912649T patent/ATE107504T1/de not_active IP Right Cessation
- 1989-10-26 DE DE68916443T patent/DE68916443T2/de not_active Expired - Fee Related
-
1992
- 1992-04-14 DK DK050092A patent/DK50092A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK50092D0 (da) | 1992-04-14 |
EP0496729A1 (de) | 1992-08-05 |
DE68916443T2 (de) | 1994-12-22 |
HU9201295D0 (en) | 1992-07-28 |
EP0496729B1 (de) | 1994-06-22 |
AU637772B2 (en) | 1993-06-10 |
MC2203A1 (fr) | 1992-11-26 |
WO1991005550A1 (en) | 1991-05-02 |
JPH05502435A (ja) | 1993-04-28 |
IE893450A1 (en) | 1991-04-24 |
ZA898143B (en) | 1991-06-26 |
DK50092A (da) | 1992-04-14 |
DE68916443D1 (de) | 1994-07-28 |
GB8923254D0 (en) | 1989-12-06 |
AU4519289A (en) | 1991-05-16 |
CA2001566A1 (en) | 1991-04-16 |
ATE107504T1 (de) | 1994-07-15 |
HUT60431A (en) | 1992-09-28 |
HU208625B (en) | 1993-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
RU95107881A (ru) | Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата | |
ES2171469T3 (es) | Composicion administrada por via nasal y preparacion que la contiene. | |
RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
AP1849A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
KR970032872A (ko) | 아세틸살리실산을 함유하는 피부 손상 처치용 약물 | |
US5011841A (en) | Treatment of depression | |
KR920703038A (ko) | 크립토스포리디아중(cryptosporidiosis)의 치료약제 | |
KR920700626A (ko) | 톡소플라스마병의 치료용 약제 | |
RU98101105A (ru) | Новое применение в медицинских целях | |
KR970005283A (ko) | 심근경색발생 후의 환자를 처치하기 위한 서트랄린의 용도 | |
KR950702413A (ko) | 암치료에 2-(4-(4-클로로페닐)시클로헥실)-3-히드록시-1, 4-나프토퀴논을 사용하는 방법(use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer) | |
KR920703067A (ko) | 말초 신경질환 및 뇌질환 치료용 L-α-글리세로포르포릴-D-미오-이노시톨 | |
KR930017579A (ko) | 신경 보호제 | |
KR890001558A (ko) | 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염 | |
US4716177A (en) | Tolrestat for inhibition of weight gain | |
KR910018026A (ko) | α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제 | |
KR920016104A (ko) | 노인성 특발적 백내장 약제 제조를 위한 칼시토닌의 국소적용 용도 및 이의 약제학적 조성물 | |
KR930701997A (ko) | 항우울제로서의 1-치환된 페녹사티인 유도체 | |
SE8304818D0 (sv) | A medicine having anti-ulcer, spasmolytic and locally anesthetic effect | |
KR950016757A (ko) | 약물중독 치료제 조성물 | |
EP0245951A2 (de) | Verwendung von Tolrestat oder einem Salz davon als antihypertensives Mittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |